Basics VYNE Therapeutics Inc. IPO Date: January 22, 2018 Sector: Healthcare Market Cap: $16.66M Activated in VL: True Average Daily Range Avg Daily Range: $0.10 | 4.08% Avg Daily Range (30 D): $0.05 | 3.82% Avg Daily Range (90 D): $0.07 | 3.68% Institutional Daily Volume Avg Daily Volume: .91M Avg Daily Volume (30 D): .21M Avg Daily Volume (90 D): .13M Trade Size Avg Trade Size (Sh.): 312 Avg Trade Size (Sh.) (30 D): 340 Avg Trade Size (Sh.) (90 D): 281 Institutional Trades Total Inst.Trades: 35 Avg Inst. Trade: $1.59M Avg Inst. Trade (30 D): $.55M Avg Inst. Trade (90 D): $.8M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.91M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 31.93K         News Jun 26, 2024 @ 12:00 PM VYNE Therapeutics to Participate in Leerink Partne... Source: VYNE Therapeutics Inc. Jun 14, 2024 @ 1:01 PM Analyst Scoreboard: 4 Ratings For VYNE Therapeutic... Source: Benzinga Insights Jun 13, 2024 @ 1:02 PM VYNE Therapeutics Announces Dosing of First Partic... Source: VYNE Therapeutics Inc. May 9, 2024 @ 1:15 PM VYNE Therapeutics Inc. (VYNE) Reports Q1 Loss, Mis... Source: Zacks Equity Research May 8, 2024 @ 12:10 PM Verve Therapeutics (VERV) Reports Q1 Loss, Tops Re... Source: Zacks Equity Research Financials   TTM Q4 2024 FY 2024 Basic EPS $-.2 $-.28 $-.93 Diluted EPS $-.2 $-.28 $-.93 Revenue $ .2M $ .08M $ .5M Gross Profit $ $ $ Net Income / Loss $ -8.61M $ -12.02M $ -39.83M Operating Income / Loss $ -9.2M $ -12.77M $ -43.64M Cost of Revenue $ $ $ Net Cash Flow $ 8.28M $ 3.61M $ -10.75M PE Ratio     Splits Feb 13, 2023:   1:18 Feb 16, 2021:   1:4